Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

Br J Haematol. 2010 Feb;148(3):480-2. doi: 10.1111/j.1365-2141.2009.07963.x. Epub 2009 Oct 15.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Hodgkin Disease / drug therapy*
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Recurrence
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Treatment Outcome
  • Young Adult

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide